The transcription factors OCT4, SOX2, and NANOG have essential roles in early development and are required for the propagation of undifferentiated embryonic stem (ES) cells in culture. To gain insights into transcriptional regulation of human ES cells, we have identified OCT4, SOX2, and NANOG target genes using genome-scale location analysis. We found, surprisingly, that OCT4, SOX2, and NANOG co-occupy a substantial portion of their target genes. These target genes frequently encode transcription factors, many of which are developmentally important homeodomain proteins. Our data also indicate that OCT4, SOX2, and NANOG collaborate to form regulatory circuitry consisting of autoregulatory and feedforward loops. These results provide new insights into the transcriptional regulation of stem cells and reveal how OCT4, SOX2, and NANOG contribute to pluripotency and self-renewal.
To further our understanding of the means by which OCT4, SOX2, and NANOG control the pluripotency and self-renewal of human ES cells, we have used genomescale location analysis (chromatin immunoprecipitation coupled with DNA microarrays) to identify the target genes of all three regulators in vivo. The results reveal that OCT4, SOX2, and NANOG co-occupy the promoters of a large population of genes, that many of these target genes encode developmentally important homeodomain transcription factors, and that these regulators contribute to specialized regulatory circuits in ES cells.
Results and Discussion

OCT4 Promoter Occupancy in Human ES Cells
DNA sequences occupied by OCT4 in human H9 ES cells (NIH code WA09; Supplemental Data) were identified in a replicate set of experiments using chromatin immunoprecipitation (ChIP) combined with DNA microarrays ( Figure 1A and Supplemental Data). For this purpose, DNA microarrays were designed that contain 60-mer oligonucleotide probes covering the region from −8 kb to +2 kb relative to the transcript start sites for 17,917 annotated human genes. Although some transcription factors are known to regulate genes from distances greater than 8 kb, 98% of known binding sites for human transcription factors occur within 8 kb of target genes ( Figure S1 ). The sites occupied by OCT4 were identified as peaks of ChIP-enriched DNA that span closely neighboring probes ( Figure 1B) . OCT4 was associated with 623 (3%) of the promoter regions for known protein-coding genes and 5 (3%) of the promoters for known miRNA genes in human ES cells (Table S2) 
OCT4, SOX2, and NANOG Co-Occupy Many Target Genes
We next identified, with location analysis, protein-coding and miRNA genes targeted by the stem cell regulators SOX2 and NANOG. SOX2 and NANOG were found associated with 1271 (7%) and 1687 (9%), respectively, of the promoter regions for known protein-coding genes in human ES cells (Tables S2-S4 ). It was immediately evident that many of the target genes were shared by OCT4, SOX2, and NANOG (Figure 2A) . Examples of protein-coding genes that are co-occupied by the three regulators are shown in Figure 2B (Table S5) . Control experiments showed that the set of promoters bound by the cell-cycle transcription factor E2F4 in these human ES cells did not overlap substantially with those bound by the three stem cell regulators (Tables S2 and  S6 Table  S2 ). It was surprising, however, to find that >90% of promoter regions bound by both OCT4 and SOX2 were also occupied by NANOG. Furthermore, we found that OCT4, SOX2, and NANOG binding sites occurred in close proximity at nearly all of the genes that they cooccupied ( Figure 2C ). These data suggest that OCT4, SOX2, and NANOG function together to regulate a significant proportion of their target genes in human ES cells. (Table S2 ). The results showed that one or more of the stem cell transcription factors occupied 1303 actively transcribed genes and 957 inactive genes.
The importance of OCT4, SOX2, and NANOG for early development and ES cell identity led us to focus additional analyses on the set of 353 genes that are cooccupied by these regulators in human ES cells (Table  S5) . We first identified transcriptionally active genes. Transcripts were consistently detected in ES cells for approximately half of the genes co-bound by OCT4, SOX2, and NANOG. Among these active genes, several encoding transcription factors (e.g., OCT4, SOX2, NANOG, STAT3, ZIC3) and components of the Tgf-β (e.g., TDGF1, LEFTY2/EBAF) and Wnt (e.g., DKK1, FRAT2) signaling pathways were notable targets. Recent studies have shown that Tgf-β and Wnt signaling play a role in pluripotency and self-renewal in both mouse and human ES cells (James et al., 2005; Sato et al., 2004). These observations suggest that OCT4, SOX2, and NANOG promote pluripotency and selfrenewal through positive regulation of their own genes and genes encoding components of these key signaling pathways.
Among transcriptionally inactive genes co-occupied by OCT4, SOX2, and NANOG, we noted a striking enrichment for transcription factor genes (p < 10 −18 ; Table  S7 ), many of which have been implicated in developmental processes. These included genes that specify transcription factors important for differentiation into extra-embryonic, endodermal, mesodermal, and ectodermal lineages (e.g., ESX1l, HOXB1, MEIS1, PAX6, LHX5, LBX1, MYF5, ONECUT1) (Table S5) . Moreover, nearly half of the transcription factor genes that were bound by the three regulators and transcriptionally inactive encoded developmentally important homeodomain proteins (Table 2 ). These results demonstrate that OCT4, SOX2, and NANOG occupy a set of repressed genes that are key to developmental processes.
To determine which of the OCT4, SOX2, and NANOG bound genes were preferentially expressed in ES cells, we compared expression datasets (Abeyta et Figure 3B ). We expected that for any set of genes, there would be a characteristic change in expression levels between ES cells and differentiated cells. If OCT4, SOX2, and NANOG do not regulate the genes they occupy, then these genes should have the same general expression profile as the control population. We found, however, a significant shift in the distribution of expression changes for genes occupied by OCT4, SOX2, and NANOG (p value < 0.001). Taken together, these data support the model that OCT4, SOX2, and NANOG functionally regulate the genes they occupy and suggest that loss of these regulators upon differentiation results in increased expression of genes necessary for development and reduced expression of a set of genes required for the maintenance of stem cell identity. Our results suggest that OCT4, SOX2, and NANOG contribute to pluripotency and self-renewal by activating their own genes and genes encoding components of key signaling pathways and by repressing genes that are key to developmental processes. It is presently unclear how the three key regulators can activate some genes and repress others. It is likely that the activity of these key transcription factors is further controlled by additional cofactors, by the precise levels of OCT4, SOX2, and NANOG, and by posttranslational modifications.
Core Transcriptional Regulatory Circuitry in ES Cells
In order to identify regulatory network motifs associated with OCT4, SOX2, and NANOG, we assumed that regulator binding to a gene implies regulatory control and used algorithms that were previously devised to discover such regulatory circuits in yeast ( Our results also showed that OCT4, SOX2, and NANOG This model also provides a mechanistic framework for understanding how this is accomplished through regulation of specific sets of genes that control cell-fate specification.
Concluding Remarks
Discovering how gene expression programs are controlled in living cells promises to improve our understanding of cell biology, development, and human health. Identifying the target genes for key transcriptional regulators of human stem cells is a first critical step in the process of understanding these transcriptional regulatory networks and learning how they control cell identity. Mapping OCT4, SOX2, and NANOG to their binding sites within known promoters has revealed that these regulators collaborate to form in ES cells regulatory circuitry consisting of specialized autoregulatory and feedforward loops. Continued advances in our ability to culture and genetically manipulate human ES cells will allow us to test and manipulate this circuitry. Identification of the targets of additional transcription factors and chromatin regulators using the approaches described here should allow investigators to produce a more comprehensive map of transcriptional regulatory circuitry in these cells. Connecting signaling pathways to this circuit map may reveal how these pluripotent cells can be stimulated to differentiate into different cell types or how to reprogram differentiated cells back to a pluripotent state.
Experimental Procedures
Growth Conditions for Human Embryonic Stem Cells
Human embryonic stem (ES) cells were obtained from WiCell (Madison, Wisconsin; NIH Code WA09). Detailed protocol information on human ES cell growth conditions and culture reagents are available at http://www.mcb.harvard.edu/melton/hues. Briefly, passage 34 cells were grown in KO-DMEM medium supplemented with serum replacement, basic fibroblast growth factor (bFGF), recombinant human leukemia inhibitory factor (LIF), and a human plasma protein fraction. In order to minimize any MEF contribution in our analysis, H9 cells were cultured on a low density of irradiated murine embryonic fibroblasts (ICR MEFs) resulting in a ratio of approximately >8:1 H9 cell to MEF. The culture of H9 on low-density MEFs had no adverse effects on cell morphology, growth rate, or undifferentiated status as compared to cells grown under typical conditions. In addition, immunohistochemistry for pluripotency markers (e.g., OCT4, SSEA-3) indicated that H9 cells grown on a minimal feeder layer maintained the ability to generate derivates of ectoderm, mesoderm, and endoderm upon differentiation (Figures S3 and S4 ).
Antibodies
The NANOG (AF1997) and SOX2 (AF2018) antibodies used in this study were immunoaffinity purified against the human proteins and shown to recognize their target proteins in Western blots and by immunocytochemistry (R&D Systems Minneapolis, Minnesota). Multiple OCT4 antibodies directed against different portions of the protein (AF1759 R&D Systems, sc-8628 Santa Cruz, sc-9081 Santa Cruz), some of which were immunoaffinity purified, were used in this study and have been shown to recognize their target protein in Western blots and by immunocytochemistry. The E2F4 antibody used in this study was obtained from Santa Cruz (sc-1082) and has been shown to recognize E2F4-responsive genes identified in previous ChIP studies (Table S2) 
Chromatin Immunoprecipitation
Protocols describing all materials and methods can be downloaded from http://jura.wi.mit.edu/young/hESRegulation/.
Human embryonic stem cells were grown to a final count of 5 × 10 7 -1 × 10 8 cells for each location analysis reaction. Cells were chemically crosslinked by the addition of one-tenth volume of fresh 11% formaldehyde solution for 15 min at room temperature. Cells were rinsed twice with 1 × PBS and harvested using a silicon scraper and flash frozen in liquid nitrogen and stored at −80°C prior to use. Cells were resuspended, lysed in lysis buffers, and sonicated to solubilize and shear crosslinked DNA. Sonication conditions vary depending on cells, culture conditions, crosslinking, and equipment. We used a Misonix Sonicator 3000 and sonicated at power 7 for 10 × 30 s pulses (90 s pause between pulses) at 4°C while samples were immersed in an ice bath. The resulting wholecell extract was incubated overnight at 4°C with 100 l of Dynal Protein G magnetic beads that had been preincubated with 10 g of the appropriate antibody. Beads were washed five times with RIPA buffer and one time with TE containing 50 mM NaCl. Bound complexes were eluted from the beads by heating at 65°C with occasional vortexing, and crosslinking was reversed by overnight incubation at 65°C. Whole-cell extract DNA (reserved from the sonication step) was also treated for crosslink reversal. Immunoprecipitated DNA and whole-cell extract DNA were then purified by treatment with RNaseA, proteinase K, and multiple phenol:chloroform: isoamyl alcohol extractions. Purified DNA was blunted and ligated to linker and amplified using a two-stage PCR protocol. Amplified DNA was labeled and purified using Invitrogen Bioprime random primer labeling kits (immunoenriched DNA was labeled with Cy5 fluorophore, whole-cell extract DNA was labeled with Cy3 fluorophore). Labeled DNA was combined (5-6 g each of immunoenriched and whole-cell extract DNA) and hybridized to arrays in Agilent hybridization chambers for 40 hr at 40°C. Arrays were then washed and scanned (Supplemental Data).
Array Design and Data Extraction
The design of the 10-slide oligo-based promoter arrays used in this study and data extraction methods are described in detail in Supplemental Data. Arrays were manufactured by Agilent Technologies (http://www.agilent.com).
Supplemental Data
Supplemental Data include seven figures, seven tables, and Supplemental text and can be found with this article online at http:// www.cell.com/cgi/content/full/122/6/947/DC1/.
